Clinical Trial Update: Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. [Phase 2, Phase 3]

View source ↗

Summary

This document reports a completed Phase 2/3 trial evaluating pantoprazole 40 mg daily vs placebo in GERD, with outcomes based on power spectral analysis of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Southern Arizona VA Health Care System | Conditions: Gastroesophageal Reflux Disease | Phase 2, Phase 3 | Status: COMPLETED